about
Self-management of fatal familial insomnia. Part 2: case reportMinimization and management of wastes from biomedical research.Prions and blood products.Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.Ultra-high-pressure inactivation of prion infectivity in processed meat: a practical method to prevent human infection.Inactivation of prions by acidic sodium dodecyl sulfateHomogenous photocatalytic decontamination of prion infected stainless steel and titanium surfacesRapid assessment of bovine spongiform encephalopathy prion inactivation by heat treatment in yellow grease produced in the industrial manufacturing process of meat and bone mealsEnzymatic formulation capable of degrading scrapie prion under mild digestion conditionsComparative study of surgical instruments from sterile-service departments for presence of residual gram-negative endotoxin and proteinaceous depositsRapid and Highly Sensitive Detection of Variant Creutzfeldt-Jakob Disease Abnormal Prion Protein on Steel Surfaces by Protein Misfolding Cyclic Amplification: Application to Prion Decontamination Studies.An overview of transmissible spongiform encephalopathies.Spiroplasma as a candidate agent for the transmissible spongiform encephalopathies.Investigation of a possible iatrogenic case of Creutzfeldt-Jakob disease after a neurosurgical procedure.Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces.Fate of prions in soil: a review.Are new supraglottic airway devices, tracheal tubes and airway viewing devices cost-effective?Strain Typing of Prion Diseases Using In Vivo Mouse Models.Bioassays and Inactivation of Prions.Aβ seeds and prions: How close the fit?On the heat stability of amyloid-based biological activity: insights from thermal degradation of insulin fibrils.Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.Surveillance for transmissible spongiform encephalopathy in scavengers of white-tailed deer carcasses in the chronic wasting disease area of Wisconsin.MSA prions exhibit remarkable stability and resistance to inactivation.Effect of heating on the stability of amyloid A (AA) fibrils and the intra- and cross-species transmission of AA amyloidosis.Evaluation of the Application for new alternative biodiesel production process for rendered fat of Cat 1 (BDI‐RepCat process, AT)Introducing new anaesthetic equipment into clinical practice.Inhibitors of gastric acid secretion increase the risk of prion infection in mice.Ethical analysis of communicating the risk of iatrogenic Creutzfeldt-Jakob disease.A method for surveying instrument decontamination procedures in general dental practice.Some physico-chemical parameters that influence proteinase K resistance and the infectivity of PrPSc after high pressure treatment.Bovine Spongiform Encephalopathy (BSE) – Infectious, Contagious, Zoonotic or Production Disease?
P2860
Q24683303-7F110EA9-7D6A-4D1D-A767-22B01FFC7423Q24811606-A9CBF2AB-FA31-43D0-AC93-BB214C3F89DDQ33925903-E0F7C2CA-FB70-40A4-9819-3ACAAFD6631EQ34057924-CCC2CDD9-1451-49B8-8961-DD586BF02CA3Q34195057-B76B57AE-24E0-4853-99DB-1C0605F65737Q34232938-352B8F63-1517-4309-9B0F-234BBFE1183DQ34362526-ACAC76ED-322F-4632-8E89-60B7A027CB8DQ34802813-D1BA1A99-4707-4053-A952-B96509BE35C4Q34846780-BB32B8E7-A2A2-4AD3-BA9A-987CA05E5789Q35073527-086426C5-6027-4FF7-A2F9-7ED3EF4B9219Q35901624-1535C28C-B084-4284-A284-6735B77D914DQ36177322-2DBAF538-BE84-4C54-88C9-B582BC1A6240Q36282035-4DD8FB8A-E5CD-47E1-AA71-EE909A34BE1CQ36676203-6BD642B5-3526-442D-8DF2-57F600711D34Q37088596-0CC11187-7457-4CBF-94EA-501CAB6ED2FEQ37869096-F492AC12-A1EA-44FD-91EF-89D83AAD3497Q38265078-255D943E-510D-484A-911D-E302FEDF44AFQ38598355-1B4E7FC1-B158-4EA5-A811-39B83A12A309Q38936788-C6F9F1B7-3A9E-46FF-9422-28792377CD05Q41358671-EB421C92-F4DF-458F-B0E9-4646F3D838F6Q41882869-BFD9CE50-5AB9-4617-803C-9467221AECE8Q42318354-4665EF2C-6911-4D87-B9C7-9DBF60385DB3Q43457909-3D34CE78-5F33-45B7-AF38-C60B3B2570C0Q46412176-EA910737-1754-45FA-B6D8-844ABD80BF82Q46636597-83D229EC-B339-4686-B0B5-64EA717C0264Q47161028-5BC23427-9359-4817-B2BE-B6840832F070Q48494886-B5DD06D7-7BCE-425F-9946-EC42A5AF00F5Q48887100-F24D4C0A-92E0-4331-941B-414882D1CBADQ49134178-1F378068-3A77-4F91-8B9D-6B989532E43CQ51065573-E0DE9D97-02A3-467C-A89C-DA5C36DC161CQ51814891-2FDA4259-0EB6-44B8-AF91-E73B27150B4AQ59148635-0CF3464B-40E5-4356-BDF4-9F52D7153307
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Inactivation of prions by physical and chemical means.
@ast
Inactivation of prions by physical and chemical means.
@en
type
label
Inactivation of prions by physical and chemical means.
@ast
Inactivation of prions by physical and chemical means.
@en
prefLabel
Inactivation of prions by physical and chemical means.
@ast
Inactivation of prions by physical and chemical means.
@en
P1476
Inactivation of prions by physical and chemical means.
@en
P2093
P304
P356
10.1016/S0195-6701(99)90067-1
P478
P577
1999-12-01T00:00:00Z